SC
SGFY

Sagefield Capital’s Signify Health, Inc. SGFY Stock Holding History

Sagefield Capital’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,300
Closed -$417K – 111
2022
Q3 		$417K Buy
+14,300
New +$329K 0.13% 91

Other funds holding SGFY

NMC
New Mountain Capital New York $110M AUM 51.63% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Sagefield Capital's SGFY Position: Q4 2022 in Review

Sagefield Capital sold out of Signify Health, Inc. (SGFY) in Q4 2022, closing a stake of 14,300 shares — an estimated $417K sold.

Sagefield Capital first reported a position in SGFY in Q3 2022 and held it in 1 quarter. The position peaked at $417K in Q3 2022. 205 funds tracked by Wall St. Rank hold SGFY as of Q4 2022.

  • Sagefield Capital reported no remaining Signify Health, Inc. position as of Q4 2022 after selling out during the quarter.
  • Sagefield Capital sold 14,300 Signify Health, Inc. shares in Q4 2022, an estimated $417K.
  • Sagefield Capital first reported a position in Signify Health, Inc. in Q3 2022 and held it in 1 quarter.
  • Sagefield Capital's Signify Health, Inc. position peaked at $417K in Q3 2022.
  • 205 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q4 2022.

Based on Sagefield Capital's 13F filing for Q4 2022, filed 14 Feb 2023.